menu search

Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate

Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...

March 2, 2022, 8:06 am

Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate

Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...

March 2, 2022, 8:06 am

Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate

Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...

March 2, 2022, 8:06 am

Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...

March 2, 2022, 8:05 am

Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...

March 2, 2022, 8:05 am

Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...

March 2, 2022, 8:05 am

New study questions pfizer vaccine effectiveness in kids

CNBC's Meg Tirrell joins Shep Smith to report on a new study that raises questions about the effectiveness of Pfizer's v...

March 1, 2022, 8:49 pm

New study questions pfizer vaccine effectiveness in kids

CNBC's Meg Tirrell joins Shep Smith to report on a new study that raises questions about the effectiveness of Pfizer's v...

March 1, 2022, 8:49 pm

New study questions pfizer vaccine effectiveness in kids

CNBC's Meg Tirrell joins Shep Smith to report on a new study that raises questions about the effectiveness of Pfizer's v...

March 1, 2022, 8:49 pm

Why novavax stock is jumping today

Investors like the vaccine maker's 2022 revenue outlook....

March 1, 2022, 12:13 pm

Why novavax stock is jumping today

Investors like the vaccine maker's 2022 revenue outlook....

March 1, 2022, 12:13 pm

Why novavax stock is jumping today

Investors like the vaccine maker's 2022 revenue outlook....

March 1, 2022, 12:13 pm

Pfizer covid-19 vaccine 12% effective against omicron in kids 5-11, study finds

Yahoo Finance's Anjalee Khemlani joins the Live show to report new findings on Pfizer's COVID-19 vaccin...

March 1, 2022, 11:43 am

Pfizer covid-19 vaccine 12% effective against omicron in kids 5-11, study finds

Yahoo Finance's Anjalee Khemlani joins the Live show to report new findings on Pfizer's COVID-19 vaccin...

March 1, 2022, 11:43 am

Pfizer covid-19 vaccine 12% effective against omicron in kids 5-11, study finds

Yahoo Finance's Anjalee Khemlani joins the Live show to report new findings on Pfizer's COVID-19 vaccin...

March 1, 2022, 11:43 am

Cardiol therapeutics receives clearance to expand eligible patient group for its lancer study

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food and Drug Administration and its counterparts in ...

March 1, 2022, 11:34 am

Cardiol therapeutics receives clearance to expand eligible patient group for its lancer study

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food and Drug Administration and its counterparts in ...

March 1, 2022, 11:34 am

Cardiol therapeutics receives clearance to expand eligible patient group for its lancer study

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food and Drug Administration and its counterparts in ...

March 1, 2022, 11:34 am

Novavax's revenue falls short. management expects a surge.

The Covid-19 vaccine maker Novavax expects revenue of between $4 billion and $5 billion in 2022, That c...

March 1, 2022, 6:29 am

Novavax's revenue falls short. management expects a surge.

The Covid-19 vaccine maker Novavax expects revenue of between $4 billion and $5 billion in 2022, That c...

March 1, 2022, 6:29 am


Search within

Pages Search Results: